Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
2018 Standout
The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts
2019
Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions
2021 StandoutNobel
Messenger RNA-Based Vaccines Against Infectious Diseases
2020 StandoutNobel
American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis
2011 Standout
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
2015 Standout
Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance
2018 StandoutNobel
Niemann-Pick disease type C
2010 Standout
Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease
2007
Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey
2004 Standout
A novel role for 12/15-lipoxygenase in regulating autophagy
2014 StandoutNobel
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Enzyme replacement therapy in Anderson-Fabry's disease: beneficial clinical effect on vital organ function
2002
A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)
2006
Vaccine adjuvants – understanding molecular mechanisms to improve vaccines
2014 StandoutNobel
Enzyme replacement therapy with agalsidase beta in kidney transplant patients with Fabry disease: A pilot study
2004
Small fiber neuropathy in Fabry disease
2012
Gene therapy for mucopolysaccharidosis
2007
Structure of sulfamidase provides insight into the molecular pathology of mucopolysaccharidosis IIIA
2014
Cell culture-derived influenza vaccines in the severe 2017–2018 epidemic season: a step towards improved influenza vaccine effectiveness
2018
Bringing influenza vaccines into the 21st century
2013
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Effectiveness of Seasonal Influenza Vaccines in the United States During a Season With Circulation of All Three Vaccine Strains
2012
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Influenza: Options to Improve Pandemic Preparation
2012 Science
Vaccinology in the era of high-throughput biology
2015
Prevention and Control of Seasonal Influenza with Vaccines
2016
Nucleoside-Modified mRNA-Based Influenza Vaccines Circumvent Problems Associated with H3N2 Vaccine Strain Egg Adaptation
2022 StandoutNobel
More on influenza vaccine in young children.
2012
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Mouse Norovirus Infection Arrests Host Cell Translation Uncoupled from the Stress Granule-PKR-eIF2α Axis
2019
Evolution of the immune system in humans from infancy to old age
2015 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Treatment of Fabry Disease: Outcome of a Comparative Trial with Agalsidase Alfa or Beta at a Dose of 0.2 mg/kg
2007
Formylglycine, a Post-Translationally Generated Residue with Unique Catalytic Capabilities and Biotechnology Applications
2014 StandoutNobel
The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations
2010
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Prevalence of Fabry Disease in Female Patients With Late-Onset Hypertrophic Cardiomyopathy
2004
The mechanism of action of MF59 – An innately attractive adjuvant formulation
2012
A severity scoring tool to assess the neurological features of neuronopathic Gaucher disease
2007
Works of Frank Baehner being referenced
Onset and progression of the Anderson–Fabry disease related cardiomyopathy
2008
Cardiac manifestations of Anderson–Fabry disease in heterozygous females
2002
Oil-in-Water Emulsion Adjuvant with Influenza Vaccine in Young Children
2011
Impact of Pre-Exposure History and Host Genetics on Antibody Avidity Following Norovirus Vaccination
2017
Cardiac manifestations of Anderson‐Fabry disease in children and adolescents
2008
The Mainz Severity Score Index: a new instrument for quantifying the Anderson–Fabry disease phenotype, and the response of patients to enzyme replacement therapy
2004
Broad Blockade Antibody Responses in Human Volunteers after Immunization with a Multivalent Norovirus VLP Candidate Vaccine: Immunological Analyses from a Phase I Clinical Trial
2015
Cumulative incidence rates of the mucopolysaccharidoses in Germany
2005
Cardiac Involvement in Anderson-Fabry Disease
2002
Enzyme replacement therapy in heterozygous females with Fabry disease: Results of a phase IIIB study
2003